2 Third Avenue Management Collegium Pharmaceutical Trades
Third Avenue Management acquired 108 Thousand Collegium Pharmaceutical shares worth $3.51 Million. That's 0.58% of their equity portfolio (43rd largest holding). The stake costed the investor $2.96 Million, netting the investor a gain of 19% so far.
Avg closing price
Price range
Increased shares by 30.1% (+25 Thousand shares)
Q1 2024
Avg closing price
$34.99
Price range
$31.23
-
$40.91
New holding (+83.1 Thousand shares)
Q4 2023
Avg closing price
$25.05
Price range
$21.16
-
$30.80
News about Collegium Pharmaceutical Inc and Third Avenue Management
Brandywine Global Investment Management LLC Boosts Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
… Selling at Collegium Pharmaceutical In other Collegium Pharmaceutical news, EVP … stock. Collegium Pharmaceutical Profile (Free Report) Collegium Pharmaceu...
Mutual of America Capital Management LLC Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
… year. Collegium Pharmaceutical Profile (Free Report) Collegium Pharmaceutical , Inc, a … specialty pharmaceutical company, develops and … 39; ratings for C...